Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Non-Current Deffered Revenue (2019 - 2025)

Historic Non-Current Deffered Revenue for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $406000.0.

  • Outset Medical's Non-Current Deffered Revenue fell 5189.57% to $406000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $406000.0, marking a year-over-year decrease of 5189.57%. This contributed to the annual value of $406000.0 for FY2025, which is 5189.57% down from last year.
  • As of Q4 2025, Outset Medical's Non-Current Deffered Revenue stood at $406000.0, which was down 5189.57% from $676000.0 recorded in Q3 2025.
  • Outset Medical's Non-Current Deffered Revenue's 5-year high stood at $844000.0 during Q4 2024, with a 5-year trough of $77000.0 in Q3 2024.
  • Its 5-year average for Non-Current Deffered Revenue is $313950.0, with a median of $190000.0 in 2022.
  • In the last 5 years, Outset Medical's Non-Current Deffered Revenue crashed by 8074.2% in 2021 and then surged by 77792.21% in 2025.
  • Quarter analysis of 5 years shows Outset Medical's Non-Current Deffered Revenue stood at $312000.0 in 2021, then crashed by 51.6% to $151000.0 in 2022, then tumbled by 33.11% to $101000.0 in 2023, then surged by 735.64% to $844000.0 in 2024, then plummeted by 51.9% to $406000.0 in 2025.
  • Its last three reported values are $406000.0 in Q4 2025, $676000.0 for Q3 2025, and $587000.0 during Q2 2025.